Large Volume Parenteral Market Top Player 2018: Baxter International Inc., Teva Pharmaceutical Industries Limited, Kelun Pharmaceutical Inc., BAG Healthcare GmbH, Hospira

According to report by Lancet Commission for Global Surgery, 2015, large number of unmet surgical needs in Asia Pacific region are expected to provide potential opportunity for large volume parenteral market due to use of large volume parenteral to administer therapeutics doses or nutrition. Parenteral nutrition plays a key role in patients who are unable to take diet normally or unconscious. In such cases nutrition is administered through large volume parenteral. According to study published in Journal of Critical Care in 2017, an estimate of 40,000 people are in need of such parenteral nutrition annually in the U.S., which in turn is driving growth of the market.

Download PDF Brochure of Research Report: https://www.coherentmarketinsights.com/insight/request-pdf/1323

Key players operating in large volume parenteral market include Baxter International Inc., Teva Pharmaceutical Industries Limited, Kelun Pharmaceutical Inc., BAG Healthcare GmbH, Hospira, Inc., Patheon Inc., Otsuka Pharmaceutical, Wockhardt Ltd., Southwest Pharmaceutical Co. Ltd., and Cook Pharmica LLC.

In January 2018, Baxter International Inc. announced a distribution agreement for the U.S. launch of the Arisure Closed System Transfer device, which has several component to prevent contaminants from entering the intravenous medication delivery system. This avoids the entry of hazardous substances while administration of therapy. Baxter International Inc. also completed the acquisition of the Claris Injectable Limited in July 2017, which is expected to improve Baxter’s presence in generic injectable market.

According to World Health Organization (WHO), 2017, an estimate of 40 million people need palliative care worldwide. Around 78% among those people, live in low- and middle-income economies and only 14% of people in need of palliative care receives it. Disease which require high palliative care are cardiovascular diseases (38.5%), cancer (34%), chronic respiratory diseases (10.3%), AIDS (5.7%) and diabetes (4.6%), kidney failure, chronic liver disease. This creates potential opportunity for large volume parenteral market players.

Increasing number of surgeries are expected to propel growth for the large volume parenteral market worldwide. For instance, according to World Bank statistics, in 2012, around 4511 surgeries were performed per 1,00,000 population across the globe. As per Lancet Commission for Global Surgery, 2015, an estimate of 143 million unmet surgical need per year, surgical need in turn drives large volume parenteral market as they are essential part of pre and post-operative care.

Get Request Sample Copy of Research Report: https://www.coherentmarketinsights.com/insight/request-sample/1323

Large Volume Parenteral Market Taxonomy:

On the basis of application:

Fluid balance therapy
Therapeutic injection
Nutritional therapy
On the basis of end user:

Hospitals
Ambulatory centers
Clinics
Others

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

1001 4th Ave,, #3200, Seattle, WA 98154

This release was published on openPR.